Stability Modelling of mRNA Vaccine Quality Based on Temperature Monitoring throughout the Distribution Chain (2022)
Attributed to:
Meeting the UK demand for COVID19/SARS-CoV-2 vaccines via integrated manufacturing and supply chain optimisation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/pharmaceutics14020430
PubMed Identifier: 35214162
Publication URI: http://europepmc.org/abstract/MED/35214162
Type: Journal Article/Review
Parent Publication: Pharmaceutics
Issue: 2
ISSN: 1999-4923